Similarly, CHR-6494, a potent HASPIN inhibitor, has been demonstrated to inhibit proliferation of the triple-negative breast cancer cell line MDA-MB-231 [22] and various melanoma cell lines in vitro [23]. The gene discussed is HASPIN; the disease is melanoma.